Microvesicles in Health and Disease
- 4 February 2012
- journal article
- review article
- Published by Walter de Gruyter GmbH in Archivum Immunologiae et Therapiae Experimentalis
- Vol. 60 (2) , 107-121
Abstract
Microvesicles (or MVs) are plasma membrane-derived vesicles released from most eukaryotic cells constitutively during early apoptosis or at higher levels after chemical or physical stress conditions. This review looks at some of the functions of MVs in terms of intercellular communication and ensuant signal transduction, including the transport of proteins (unconventional protein export) as well as of mRNA and microRNA. MVs also have roles in membrane repair, the removal of misfolded proteins, and in the control of apoptosis. We also discuss the role MVs have been shown to have in invasive growth and metastasis as well as in hypoxia in tumours and cerebral ischaemia. The association of MVs in infectious and autoimmune disease is also summarised together with their possible use as therapeutic agents.Keywords
This publication has 140 references indexed in Scilit:
- A filtration-based protocol to isolate human Plasma Membrane-derived Vesicles and exosomes from blood plasmaJournal of Immunological Methods, 2011
- Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cellsProceedings of the National Academy of Sciences, 2011
- Hypoxic Tumor Cell Modulates Its Microenvironment to Enhance Angiogenic and Metastatic Potential by Secretion of Proteins and ExosomesMolecular & Cellular Proteomics, 2010
- Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent mannerCancer Letters, 2009
- Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancerBritish Journal of Cancer, 2009
- Lung cancer secreted microvesicles: Underappreciated modulators of microenvironment in expanding tumorsInternational Journal of Cancer, 2009
- Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein deliveryLeukemia, 2006
- Microparticles as regulators of inflammation: Novel players of cellular crosstalk in the rheumatic diseasesArthritis & Rheumatism, 2005
- Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancerInternational Journal of Cancer, 2004
- Development of TGF-β signalling inhibitors for cancer therapyNature Reviews Drug Discovery, 2004